Akari Therapeutics - Investor Summit Group

Akari Therapeutics

Ticker

AKTX

Website

Sector

Biotech

Tearsheet

Why Invest

Test Lead drug, first in class, differentiated bifunctional mechanism of action. Positive clinical and safety data – with two open Phase 3 clinical studies. Development pipeline – large markets with partnering upside.